161 related articles for article (PubMed ID: 3703284)
1. Very long-chain fatty acids in erythrocyte membrane sphingomyelin: detection of ALD hemizygotes and heterozygotes.
Tanaka K; Shimada M; Naruto T; Yamamoto H; Saeki Y; Sai H; Hirose G
Neurology; 1986 Jun; 36(6):791-5. PubMed ID: 3703284
[TBL] [Abstract][Full Text] [Related]
2. Very long-chain fatty acids in erythrocyte membrane phospholipids in adrenoleukodystrophy.
Tanaka K; Shimada M; Naruto T; Yamamoto H; Nishizawa K; Saeki Y
Acta Paediatr Jpn; 1989 Apr; 31(2):136-43. PubMed ID: 2516693
[TBL] [Abstract][Full Text] [Related]
3. Adrenoleukodystrophy: abnormality of very long-chain fatty acids in erythrocyte membrane phospholipids.
Antoku Y; Sakai T; Goto I; Iwashita H; Kuroiwa Y
Neurology; 1984 Nov; 34(11):1499-1501. PubMed ID: 6493501
[TBL] [Abstract][Full Text] [Related]
4. Adrenoleukodystrophy: detection of increased very long chain fatty acids by high-performance liquid chromatography.
Kobayashi T; Katayama M; Suzuki S; Tomoda H; Goto I; Kuroiwa Y
J Neurol; 1983; 230(4):209-15. PubMed ID: 6198480
[TBL] [Abstract][Full Text] [Related]
5. Adrenoleukodystrophy: increased plasma content of saturated very long chain fatty acids.
Moser HW; Moser AB; Frayer KK; Chen W; Schulman JD; O'Neill BP; Kishimoto Y
Neurology; 1981 Oct; 31(10):1241-9. PubMed ID: 7202134
[TBL] [Abstract][Full Text] [Related]
6. Abnormality of long-chain fatty acids in erythrocyte membrane sphingomyelin from patients with adrenoleukodystrophy.
Tsuji S; Suzuki M; Ariga T; Sekine M; Kuriyama M; Miyatake T
J Neurochem; 1981 Mar; 36(3):1046-9. PubMed ID: 7205256
[TBL] [Abstract][Full Text] [Related]
7. Detection of adrenoleukodystrophy by increased C26:0 fatty acid levels in leukocytes.
Molzer B; Bernheimer H; Heller R; Toifl K; Vetterlein M
Clin Chim Acta; 1982 Nov; 125(3):299-305. PubMed ID: 7172439
[TBL] [Abstract][Full Text] [Related]
8. Plasma very long chain fatty acids in 3,000 peroxisome disease patients and 29,000 controls.
Moser AB; Kreiter N; Bezman L; Lu S; Raymond GV; Naidu S; Moser HW
Ann Neurol; 1999 Jan; 45(1):100-10. PubMed ID: 9894883
[TBL] [Abstract][Full Text] [Related]
9. Adrenoleukodystrophy: elevated C26 fatty acid in cultured skin fibroblasts.
Moser HW; Moser AB; Kawamura N; Murphy J; Suzuki K; Schaumburg H; Kishimoto Y
Ann Neurol; 1980 Jun; 7(6):542-9. PubMed ID: 7436359
[TBL] [Abstract][Full Text] [Related]
10. Adrenoleukodystrophy without adrenal insufficiency and its magnetic resonance imaging.
Nishio H; Kodama S; Tsubota T; Takumi T; Takahashi T; Yokoyama S; Matsuo T
J Neurol; 1985; 232(5):265-70. PubMed ID: 4056832
[TBL] [Abstract][Full Text] [Related]
11. Adrenoleukodystrophy: abnormality of "tightly bound" fatty acids in the erythrocyte membrane proteins.
Antoku Y; Sakai T; Goto I; Miyoshino S; Iwashita H; Kuroiwa Y
Neurology; 1985 Oct; 35(10):1512-4. PubMed ID: 4033936
[TBL] [Abstract][Full Text] [Related]
12. Adrenoleukodystrophy: oleic acid lowers fibroblast saturated C22-26 fatty acids.
Rizzo WB; Watkins PA; Phillips MW; Cranin D; Campbell B; Avigan J
Neurology; 1986 Mar; 36(3):357-61. PubMed ID: 3951702
[TBL] [Abstract][Full Text] [Related]
13. Adrenoleukodystrophy: very long-chain fatty acid metabolism in fibroblasts.
Rizzo WB; Avigan J; Chemke J; Schulman JD
Neurology; 1984 Feb; 34(2):163-9. PubMed ID: 6538003
[TBL] [Abstract][Full Text] [Related]
14. Adrenoleukodystrophy: impaired oxidation of very long chain fatty acids in white blood cells, cultured skin fibroblasts, and amniocytes.
Singh I; Moser AE; Moser HW; Kishimoto Y
Pediatr Res; 1984 Mar; 18(3):286-90. PubMed ID: 6728562
[TBL] [Abstract][Full Text] [Related]
15. Profiles of very-long-chain fatty acids in plasma, fibroblasts, and blood cells in Zellweger syndrome, X-linked adrenoleukodystrophy, and rhizomelic chondrodysplasia punctata.
Schutgens RB; Bouman IW; Nijenhuis AA; Wanders RJ; Frumau ME
Clin Chem; 1993 Aug; 39(8):1632-7. PubMed ID: 8353949
[TBL] [Abstract][Full Text] [Related]
16. A simple method to diagnose adrenoleukodystrophy using a dried blood spot on filter paper.
Nishio H; Kodama S; Yokoyama S; Matsuo T; Mio T; Sumino K
Clin Chim Acta; 1986 Aug; 159(1):77-82. PubMed ID: 3757269
[TBL] [Abstract][Full Text] [Related]
17. Adrenoleukodystrophy in Israel: a genetic, clinical and biochemical study.
Chemke J; Lieberman E; Carmi R; Abarbanel Y; Costeff H; Goldhammer Y; Moser HW
Isr J Med Sci; 1984 Dec; 20(12):1123-32. PubMed ID: 6097565
[TBL] [Abstract][Full Text] [Related]
18. Determination of C20-C30 fatty acids by reversed-phase chromatographic techniques: an efficient method to quantitate minor fatty acids in serum of patients with adrenoleukodystrophy.
Alberghina M; Fiumara A; Pavone L; Giuffrida AM
Neurochem Res; 1984 Dec; 9(12):1719-27. PubMed ID: 6531070
[TBL] [Abstract][Full Text] [Related]
19. Adrenoleukodystrophy: fatty acid analysis of total glycerophospholipids in erythrocyte membranes.
Antoku Y; Sakai T; Goto I; Katafuchi Y; Sato H; Iwashita H; Kuroiwa Y
Acta Neurol Scand; 1985 Aug; 72(2):193-7. PubMed ID: 4050328
[TBL] [Abstract][Full Text] [Related]
20. The correlation between biochemical and histopathological findings in adrenoleukodystrophy.
Reinecke CJ; Knoll DP; Pretorius PJ; Steyn HS; Simpson RH
J Neurol Sci; 1985 Aug; 70(1):21-38. PubMed ID: 4045498
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
